glp-1 hype The Future of Therapies: Hype, Evidence, and the Expanding Role of Pharmacists Food Obsession: The Science Behind

Gastroenterol Res Pract 2015 , 860861, (2015)

[1] [2] Marketed under the brand names Mounjaro (for diabetes) and Zepbound (for weight management as an adjunct to reduced-calorie diet and increased physical activity), tirzepatide represents the first dual incretin receptor agonist available in clinical practice

Lamari Y, Boissard C, Moukhtar MS, Jullienne A, Rosselin G, Garel JM

doi: 10.1016/j.bbrc.2017.11.076

With the caveat that youll gain a little bit back but not a huge amount. For its part, Calibrate says it has the interests of its patients at heart, and that its acknowledging the fact that many of them are not going to stay on weight-loss drugs for life, given supply-chain shortages, insurance coverage limits, medication costs, issues with side effects, or them not wanting to stay on a medication forever